Ocular Therapeutix, Inc.
- OCUL
- NASDAQ
- Biotechnology
- Ophthalmic Drug Delivery (Hydrogel)
- Eye Therapeutics
$6.36
Today −7.50%Quote Oct 19, 2026, 03:24 PM UTC
−32.25%over the last month
Max drawdown −34.6%From 1-month high −34.6%3 months −21.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.40B
Quote Oct 19
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$23.00
+261.9% from here
Floor
$6.10
4.0% below price
Where the price sits
19 analysts
Analyst range, low to high
$14.00$30.00
- Price $6.36
- Resistance $6.45
- Consensus $23.00
The price is right under resistance. Analysts' average target sits about 262% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about OCULPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
325